Literature DB >> 35110243

Genetic and Clinical Demographics of Adult Cystic Fibrosis Patients in a Middle Eastern Population.

Irfan Shafiq1, Safia Shabeer2, Mateen Haider Uzbeck1, Zaid Zoumot1, Mohamed Abuzakouk1, Ali Saeed Wahla1.   

Abstract

OBJECTIVE: Cystic fibrosis (CF) is the commonest life-limiting inherited illness in the Caucasian population but is uncommon in the Middle East, and so the genotypes and clinical course of disease in this population is not well known.
MATERIAL AND METHODS: In this retrospective observational study, we collected and reviewed the data on CF mutations, body mass index (BMI), lung function, microbiology, and the demographics in adult CF patients in the United Arab Emirates (UAE).
RESULTS: Data was reviewed for 39 adult CF patients. The median age of adult CF patients presenting to our clinic was 25 years (interquartile range (IQR) 22-31), the median BMI was 19 (IQR 17-22), and the median percentage predicted forced expiratory volume at 1 second (FEV1) was 49.5% (IQR 38.5-62.5). S549R was the commonest mutation (n = 11, 28%) followed by ∆F508 (n = 9, 23%). Only 5 (13%) out of 39 patients were heterozygote for CF mutations which reflects the high level of consanguinity in the region. Twelve (30%) patients were diagnosed after the age of 16, and in total, 19 (48%) were diagnosed after the age of 10. Thirty-two (82%) of patients are pseudomonas colonized, and 31% had 3 or more exacerbations in the last 12 months.
CONCLUSION: The CF mutation patterns in the UAE are different from western populations with low ∆F508 prevalence, with the presence of rare mutations more specific to this region and a high rate of homozygosity. Late diagnosis, high pseudomonas colonization rate, and exacerbation frequency remain a problem in this region and lead to poor long-term outcomes.

Entities:  

Year:  2021        PMID: 35110243      PMCID: PMC8975356          DOI: 10.5152/TurkThoracJ.2021.20121

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  10 in total

1.  Determination of the prevalence of cystic fibrosis in the United Arab Emirates by genetic carrier screening.

Authors:  P M Frossard; G Lestringant; E Girodon; M Goossens; K P Dawson
Journal:  Clin Genet       Date:  1999-06       Impact factor: 4.438

2.  Cystic fibrosis of the pancreas in an oriental child.

Authors:  M Z SALAM
Journal:  Ann Paediatr       Date:  1958-04

3.  Identification of cystic fibrosis mutations in the United Arab Emirates. Mutations in brief no. 133. Online.

Authors:  P M Frossard; E Girodon; K P Dawson; N Ghanem; F Plassa; G G Lestringant; M Goossens
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

Review 4.  Cystic fibrosis.

Authors:  Jane C Davies; Eric W F W Alton; Andrew Bush
Journal:  BMJ       Date:  2007-12-15

5.  Late diagnosis defines a unique population of long-term survivors of cystic fibrosis.

Authors:  David M Rodman; Jillian M Polis; Sonya L Heltshe; Marci K Sontag; Cathy Chacon; Rachel V Rodman; Sara J Brayshaw; Gwen A Huitt; Michael D Iseman; Milene T Saavedra; Lynn M Taussig; Jeffrey S Wagener; Frank J Accurso; Jerry A Nick
Journal:  Am J Respir Crit Care Med       Date:  2004-12-10       Impact factor: 21.405

6.  Wasting as an independent predictor of mortality in patients with cystic fibrosis.

Authors:  R Sharma; V G Florea; A P Bolger; W Doehner; N D Florea; A J Coats; M E Hodson; S D Anker; M Y Henein
Journal:  Thorax       Date:  2001-10       Impact factor: 9.139

7.  Microbial colonization and lung function in adolescents with cystic fibrosis.

Authors:  Andreas Hector; Tobias Kirn; Anjali Ralhan; Ute Graepler-Mainka; Sina Berenbrinker; Joachim Riethmueller; Michael Hogardt; Marlies Wagner; Andreas Pfleger; Ingo Autenrieth; Matthias Kappler; Matthias Griese; Ernst Eber; Peter Martus; Dominik Hartl
Journal:  J Cyst Fibros       Date:  2016-02-05       Impact factor: 5.482

8.  Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry.

Authors:  Todd MacKenzie; Alex H Gifford; Kathryn A Sabadosa; Hebe B Quinton; Emily A Knapp; Christopher H Goss; Bruce C Marshall
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

9.  Survival Comparison of Patients With Cystic Fibrosis in Canada and the United States: A Population-Based Cohort Study.

Authors:  Anne L Stephenson; Jenna Sykes; Sanja Stanojevic; Bradley S Quon; Bruce C Marshall; Kristofer Petren; Josh Ostrenga; Aliza K Fink; Alexander Elbert; Christopher H Goss
Journal:  Ann Intern Med       Date:  2017-03-14       Impact factor: 25.391

Review 10.  The road for survival improvement of cystic fibrosis patients in Arab countries.

Authors:  Hanaa Banjar; Gerhild Angyalosi
Journal:  Int J Pediatr Adolesc Med       Date:  2015-06-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.